{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:45:09Z","timestamp":1791830709729,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020555","name":"Intas Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ekir.2026.106362","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:35:36Z","timestamp":1771360536000},"page":"106362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Osteoporosis and CKD-Metabolic Bone Disease Under the Same Umbrella: Insights From a Joint Scientific Symposium"],"prefix":"10.1016","volume":"11","author":[{"given":"David W.","family":"Dempster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Nickolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pazianas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.106362_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40620-023-01642-8","article-title":"The rationale for intermittent administration of PTH in the management of mineral and bone disorder of chronic kidney disease","volume":"37","author":"Pazianas","year":"2024","journal-title":"J Nephrol"},{"key":"10.1016\/j.ekir.2026.106362_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S2213-8587(24)00057-3","article-title":"Denosumab in the treatment of osteoporosis associated with chronic kidney disease","volume":"12","author":"Covic","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ekir.2026.106362_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2023.28239","article-title":"Severe hypocalcemia with denosumab among older female dialysis-dependent patients","volume":"331","author":"Bird","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106362_bib4","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in patients with CKD: time for action","volume":"11","author":"Moe","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106362_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11657-020-0702-2","article-title":"Bisphosphonate utilization across the spectrum of eGFR","volume":"15","author":"Titan","year":"2020","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.ekir.2026.106362_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.95.2467.388","article-title":"Treatment of renal osteodystrophy with dihydrotachysterol (A.T.10) and iron","volume":"95","author":"Liu","year":"1942","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ekir.2026.106362_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106362_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/j.ajkd.2020.12.024","article-title":"Osteoporosis and chronic kidney disease-mineral and bone disorder (CKD-MBD): back to basics","volume":"78","author":"Pazianas","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106362_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","article-title":"Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference","volume":"107","author":"Ketteler","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106362_bib10","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11914-017-0364-1","article-title":"Renal osteodystrophy or kidney-induced osteoporosis?","volume":"15","author":"Moe","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.ekir.2026.106362_bib11","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106362_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MNH.0000000000000992","article-title":"Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease","volume":"33","author":"Evenepoel","year":"2024","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2026.106362_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MNH.0000000000000798","article-title":"Clinical utility of bone turnover markers in patients with chronic kidney disease","volume":"31","author":"Smout","year":"2022","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ekir.2026.106362_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","volume":"36","author":"Bhattoa","year":"2025","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106362_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11914-025-00919-0","article-title":"Treatment of osteoporosis in patients with chronic kidney disease","volume":"23","author":"Laurent","year":"2025","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.ekir.2026.106362_bib16","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s00198-021-05975-7","volume":"32","author":"Evenepoel","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106362_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106362_bib18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.4804","article-title":"Hypocalcemia risk of denosumab across the spectrum of kidney disease: a population-based cohort study","volume":"38","author":"Cowan","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106362_bib19","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","article-title":"Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation","volume":"92","author":"Pimentel","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106362_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae048","article-title":"Denosumab-induced hypocalcemia in patients treated with dialysis: an avoidable complication?","volume":"17","author":"Lloret","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106362_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7326\/M24-0013","article-title":"The effect of denosumab on risk for emergently treated hypocalcemia by stage of chronic kidney disease : a target trial emulation","volume":"178","author":"Bird","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2026.106362_bib22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jbmr.4235","article-title":"Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis","volume":"36","author":"Robinson","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106362_bib23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.kint.2021.04.043","volume":"100","author":"Haarhaus","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106362_bib24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jbmr.4283","article-title":"Bisphosphonates in kidney disease-Safety First","volume":"36","author":"Khairallah","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106362_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7326\/ANNALS-24-03237","article-title":"Cardiovascular safety and fracture prevention effectiveness of denosumab versus oral bisphosphonates in patients receiving dialysis: a target trial emulation","volume":"178","author":"Masuda","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2026.106362_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ndt\/gfae197","article-title":"Multidisciplinary team approach for CKD-associated osteoporosis","volume":"40","author":"Hansen","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106362_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae070","article-title":"Celebrating 50-years: the history and future of the International Society of Bone morphometry","volume":"8","author":"Scheller","year":"2024","journal-title":"JBMR Plus"},{"key":"10.1016\/j.ekir.2026.106362_bib28","doi-asserted-by":"crossref","first-page":"ziaf028","DOI":"10.1093\/jbmrpl\/ziaf028","article-title":"ADAM: automated digital phenotyping and morphological texture analysis of bone biopsy images using deep learning","volume":"9","author":"Bharadwaj","year":"2025","journal-title":"JBMR Plus"},{"key":"10.1016\/j.ekir.2026.106362_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117309","article-title":"Histomorphometric parameters of iliac bone in healthy individuals: systematic review and meta-analysis","volume":"190","author":"Ferreira","year":"2025","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2026.106362_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/JBMR.051109","article-title":"A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide","volume":"21","author":"Lindsay","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106362_bib31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106362_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/nu15010167","article-title":"Bone disease in chronic kidney disease and kidney transplant","volume":"15","author":"Bellorin-Font","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ekir.2026.106362_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis. European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106362_bib34","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s11914-018-0491-3","article-title":"Updates in CKD-associated osteoporosis","volume":"16","author":"Khairallah","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.ekir.2026.106362_bib35","first-page":"1","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2026.106362_bib36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/jcm13041010","article-title":"Evaluating osteoporosis in chronic kidney disease: both bone quantity and quality matter","volume":"13","author":"Lloret","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ekir.2026.106362_bib37","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00223-020-00786-0","article-title":"Traditional and non-traditional risk factors for osteoporosis in CKD","volume":"108","author":"J\u00f8rgensen","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ekir.2026.106362_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S2213-8587(17)30310-8","article-title":"Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population","volume":"6","author":"Covic","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ekir.2026.106362_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semnephrol.2018.02.004","article-title":"Updates on the mechanisms and the care of cardiovascular calcification in chronic kidney disease","volume":"38","author":"H\u00e9naut","year":"2018","journal-title":"Semin Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.ekir.2026.106362_bib40","doi-asserted-by":"crossref","first-page":"i27","DOI":"10.1093\/ckj\/sfae421","article-title":"Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies","volume":"18","author":"H\u00e9naut","year":"2025","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106362_bib41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ekir.2026.106362_bib42","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/gerona\/glac171","article-title":"Abdominal aortic calcification, bone mineral density and fractures: a systematic review and meta-analysis of observational studies","volume":"78","author":"Gebre","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.ekir.2026.106362_bib43","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.3390\/ijms22169102","article-title":"Cross-talks between the cardiovascular disease-sarcopenia-osteoporosis triad and magnesium in humans","volume":"23","author":"Pickering","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2026.106362_bib44","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"Nickolas","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106362_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/ckj\/sfac230","article-title":"Management of fracture risk in CKD-traditional and novel approaches","volume":"16","author":"Haarhaus","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106362_bib46","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ndt\/gfae293","article-title":"The role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder in children and adults with chronic kidney disease, on dialysis, and after kidney transplantation-a European consensus statement","volume":"40","author":"J\u00f8rgensen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106362_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"17","author":"Gregson","year":"2022","journal-title":"Arch Osteoporos"},{"key":"10.1016\/j.ekir.2026.106362_bib48","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jbmr.1613","article-title":"A single-dose study of denosumab in patients with various degrees of renal impairment","volume":"27","author":"Block","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106362_bib49","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","author":"Jamal","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ekir.2026.106362_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11914-019-00502-4","article-title":"Stopping denosumab","volume":"17","author":"Lamy","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.ekir.2026.106362_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of Cinacalcet HCl in participants with CKD not receiving dialysis","volume":"53","author":"Chonchol","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106362_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106362_bib53","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1080\/03007995.2019.1656955","article-title":"Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial","volume":"35","author":"Bilezikian","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ekir.2026.106362_bib54","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","article-title":"Efficacy of Romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study","volume":"39","author":"Sato","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.ekir.2026.106362_bib55","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ndt\/gfy129","article-title":"Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it","volume":"34","author":"Brandenburg","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106362_bib56","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1053\/j.ajkd.2022.05.020","article-title":"Effectiveness of pharmacological interventions versus placebo or no treatment for osteoporosis in patients with CKD stages 3\u20135D: editorial summary of a Cochrane review","volume":"80","author":"Hara","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106362_bib57","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/j.ajkd.2022.08.002","article-title":"Effectiveness of pharmacological interventions for treatment of osteoporosis in patients with CKD 3\u20135D: no clear choices","volume":"80","author":"Khairallah","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106362_bib58","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/en.2016-1451","article-title":"Acute parathyroid hormone injection increases C-terminal but not intact fibroblast growth factor 23 levels","volume":"158","author":"Knab","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.ekir.2026.106362_bib59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2215\/CJN.06240611","article-title":"(1\u201334) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers","volume":"7","author":"Guti\u00e9rrez","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106362_bib60","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-010-9414-8","article-title":"Circulating fibroblast growth factor-23 increases following intermittent parathyroid hormone (1\u201334) in postmenopausal osteoporosis: association with biomarker of bone formation","volume":"87","author":"Sridharan","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ekir.2026.106362_bib61","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2009-0472","article-title":"Bone formation regulates circulating concentrations of fibroblast growth factor 23","volume":"150","author":"Samadfam","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ekir.2026.106362_bib62","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00198-016-3861-7","article-title":"Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia","volume":"28","author":"Ota","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ekir.2026.106362_bib63","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bone.2008.07.250","article-title":"Differential effects of intermittent PTH(1\u201334) and PTH(7\u201334) on bone microarchitecture and aortic calcification in experimental renal failure","volume":"43","author":"Sebastian","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.ekir.2026.106362_bib64","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2147\/CIA.S107285","article-title":"Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report","volume":"11","author":"Nishikawa","year":"2016","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.ekir.2026.106362_bib65","first-page":"1941","article-title":"Renal osteodystrophy: what\u2019s in a name?","volume":"69","author":"Malluche","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106362_bib66","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group","volume":"843","year":"1994","journal-title":"World Heath Organ Tech Rep Ser"},{"key":"10.1016\/j.ekir.2026.106362_bib67","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926025933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926025933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:04:07Z","timestamp":1784664247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926025933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2468024926025933"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106362","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis and CKD-Metabolic Bone Disease Under the Same Umbrella: Insights From a Joint Scientific Symposium","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106362"}}